CTLA4 and neoplasm: These drugs work by targeting specific molecules such as programmed death-1 (PD-1) or its ligand programmed death ligand-1 (PD-L1) and cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) to reestablish anti-tumor responses and prevent tumor cells from evading immune surveillance.